Two 5%+ dividend stocks I expect Neil Woodford to buy for his new fund

Roland Head discusses two stocks he believes will play a big role in Neil Woodford’s new Income Focus Fund.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The UK equity market is “undervalued”, according to Neil Woodford. In a recent article, the fund manager said that the fact he’s able to build a portfolio offering a 5% yield for his new Income Focus Fund “is evidence of this undervaluation”.

Unlike many of his peers in the fund management sector, Mr Woodford publishes full details of all his funds’ holdings at the end of each month. His team also provides a monthly round-up of portfolio changes that’s published on his website.

The Income Focus Fund is still in its launch period, so this information isn’t yet available for the new fund. But based on his existing holdings and previous comments, I think there are several stocks investors can be confident of seeing in the newcomer.

A key holding

Woodford Funds is already the third-largest shareholder of Legal & General Group (LSE: LGEN), with a 5% stake worth £729m. But I feel certain that this stock is also likely to be a major feature of the new Income Focus Fund.

Legal & General has long been one of Mr Woodford’s top stocks. And it’s easy to see why. The group is very profitable and generates a lot of surplus cash. Much of this is returned to shareholders through dividends. The stock currently offers a forecast yield of 6.2%.

The shares are cheaper than you might expect for such a profitable business. Legal & General generated a return on equity last year of 19%. And despite the group’s profits rising by an average of 11.5% per year since 2011, the stock currently trades on an undemanding P/E of 11.

I believe Legal & General remains a compelling buy for income and long-term growth. I’d be very surprised if it isn’t one of the top five holdings in the Woodford Income Focus Fund.

A profit maker for the fund?

Shares of outsourcing group Capita (LSE: CPI) have fallen by 47% over the last year. But this struggling firm is a top 10 holding in the Woodford Equity Income Fund. Woodford Funds is Capita’s second-largest shareholder, with a 10% stake worth about £375m.

The fund averaged down its holding last year, buying more stock after the share price collapsed. In a blog post on the Woodford Funds website in January, Capita shares were described as trading “way below the intrinsic value of the business”.

Capita’s recent 2016 results suggest to me that Woodford’s confidence will eventually be rewarded with healthy profits. Underlying earnings fell by 20% to 56.7p per share, but still provided a decent level of cover for the 31.7p per share dividend. Encouragingly, this payout was also covered comfortably by the group’s adjusted free cash flow of £409m.

The main risk remaining for equity investors is Capita’s net debt of £1.8bn. It hopes to address this problem by selling its Asset Services and Specialist Recruitment businesses during 2017.

It currently trades on a forecast P/E of 10, with a dividend yield of 5.7%. If Mr Woodford believes this dividend can be maintained, then I believe the stock is a no-brainer for the Income Focus portfolio. Aside from its income potential, it might also prove to be a very profitable turnaround buy.

Roland Head owns shares of Legal & General Group. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »